In the last trading session, 1.43 million shares of the SELLAS Life Sciences Group Inc (NASDAQ:SLS) were traded, and its beta was 2.57. Most recently the company’s share price was $1.18, and it changed around $0.02 or 1.72% from the last close, which brings the market valuation of the company to $92.73M. SLS currently trades at a discount to its 52-week high of $1.84, offering almost -55.93% off that amount. The share price’s 52-week low was $0.77, which indicates that the current value has risen by an impressive 34.75% since then.
SELLAS Life Sciences Group Inc stock received a consensus recommendation rating of Buy, based on a mean score of 1.00. If we narrow it down even further, the data shows that 0 out of 3 analysts rate the stock as a Sell; another 1 rate it as Overweight. Among the rest, 0 recommended SLS as a Hold, whereas 2 deemed it a Buy, and 0 rated it as Underweight. SELLAS Life Sciences Group Inc is expected to report earnings per share of -0.11 for the current quarter.
SELLAS Life Sciences Group Inc (NASDAQ:SLS) trade information
Instantly SLS has showed a green trend with a performance of 1.72% at the end of last trading. The performance over the last five days has remained in the green territory. The rise to weekly highs of 1.2500 on recent trading dayincreased the stock’s daily price by 5.6%. The company’s shares are currently up 13.46% year-to-date, but still up 4.42% over the last five days. On the other hand, SELLAS Life Sciences Group Inc (NASDAQ:SLS) is -27.16% down in the 30-day period.
The consensus price target as assigned by Wall Street analysts is $2.8, which translates to bulls needing to increase their stock price by 57.86% from its current value. Analyst projections state that SLS is forecast to be at a low of $2.4 and a high of $3.2.
Forecasts for the next quarter put sales growth at 0.00%.
Looking at the company’s year-over-year earnings, the past five years showed a positive earnings growth rate of 61.44%. SELLAS Life Sciences Group Inc earnings are expected to increase by 59.95% in 2025, but the outlook is positive 29.48% per year for the next five years.
SLS Dividends
SELLAS Life Sciences Group Inc’s next quarterly earnings report is expected to be released in April.
SUSQUEHANNA INTERNATIONAL GROUP, LLP, with 3.6594% or 1.64 million shares worth $1.95 million as of 2024-06-30, holds the second largest percentage of outstanding shares.
